WO2007069271A3 - Procede de purification d'une (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine - Google Patents

Procede de purification d'une (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine Download PDF

Info

Publication number
WO2007069271A3
WO2007069271A3 PCT/IN2006/000426 IN2006000426W WO2007069271A3 WO 2007069271 A3 WO2007069271 A3 WO 2007069271A3 IN 2006000426 W IN2006000426 W IN 2006000426W WO 2007069271 A3 WO2007069271 A3 WO 2007069271A3
Authority
WO
WIPO (PCT)
Prior art keywords
pentanoyl
ylmethyl
prop
carboxy
amine
Prior art date
Application number
PCT/IN2006/000426
Other languages
English (en)
Other versions
WO2007069271A2 (fr
Inventor
Pandurang Balwant Deshpande
Parven Kumar Luthra
Anand Kumar Pandey
Kamlesh Sanmukhbhai Soni
Ravindra Charudatta Ghotikar
Original Assignee
Alembic Ltd
Pandurang Balwant Deshpande
Parven Kumar Luthra
Anand Kumar Pandey
Kamlesh Sanmukhbhai Soni
Ravindra Charudatta Ghotikar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alembic Ltd, Pandurang Balwant Deshpande, Parven Kumar Luthra, Anand Kumar Pandey, Kamlesh Sanmukhbhai Soni, Ravindra Charudatta Ghotikar filed Critical Alembic Ltd
Publication of WO2007069271A2 publication Critical patent/WO2007069271A2/fr
Publication of WO2007069271A3 publication Critical patent/WO2007069271A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La présente invention concerne un procédé destiné à la purification d'une (S)-N-(1-Carboxy-2-méthyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tétrazol-5-yl)biphényl-4-ylméthyl]-amine.
PCT/IN2006/000426 2005-10-31 2006-10-19 Procede de purification d'une (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine WO2007069271A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1375MU2005 2005-10-31
IN1375/MUM/2005 2005-10-31

Publications (2)

Publication Number Publication Date
WO2007069271A2 WO2007069271A2 (fr) 2007-06-21
WO2007069271A3 true WO2007069271A3 (fr) 2008-10-02

Family

ID=38163339

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2006/000426 WO2007069271A2 (fr) 2005-10-31 2006-10-19 Procede de purification d'une (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine

Country Status (1)

Country Link
WO (1) WO2007069271A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2057132A2 (fr) 2006-07-03 2009-05-13 Aurobindo Pharma Limited Procede ameliore de prparation d'un antagoniste de l'angiotensine ii
AU2011287616A1 (en) * 2010-08-03 2013-02-28 Novartis Ag Highly crystalline valsartan
CN102617497B (zh) * 2012-02-27 2015-02-11 浙江新赛科药业有限公司 一种缬沙坦的精制方法
CN103819421A (zh) * 2014-02-21 2014-05-28 浙江华海药业股份有限公司 一种含10%以上异构体缬沙坦的精制方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004094391A2 (fr) * 2003-04-21 2004-11-04 Teva Pharmaceutical Industries Ltd. Procede de preparation du valsartan et de ses intermediaires
WO2005049587A1 (fr) * 2003-11-21 2005-06-02 Ranbaxy Laboratories Limited Procede de preparation de tetrazole de biphenyle

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004094391A2 (fr) * 2003-04-21 2004-11-04 Teva Pharmaceutical Industries Ltd. Procede de preparation du valsartan et de ses intermediaires
WO2005049587A1 (fr) * 2003-11-21 2005-06-02 Ranbaxy Laboratories Limited Procede de preparation de tetrazole de biphenyle

Also Published As

Publication number Publication date
WO2007069271A2 (fr) 2007-06-21

Similar Documents

Publication Publication Date Title
WO2003093269A3 (fr) Pyrazolopyrimidine-4-one substituee
WO2007127263A3 (fr) Utilisations thérapeutiques d'urolithines
WO2006029193A3 (fr) Processus pour preparer des tetrazoles substitues a partir d'aminotetrazole
WO2008029096A8 (fr) Composés d'activation de p53
WO2007127505A3 (fr) Composés chimiques
WO2007115821A3 (fr) Composés organiques
HK1117160A1 (en) Crystals of laquinimod sodium, and process for the manufacture thereof (laquinimod sodium)
WO2007032019A3 (fr) Procede de preparation de valsartan
WO2007014762A3 (fr) Inhibiteurs de transporteurs glyt1 et leurs utilisations dans le traitement de troubles neurologiques et neuropsychiatriques
WO2006039250A3 (fr) Sels de compose heterocyclique se liant aux chimiokines et procedes d'utilisation correspondants
WO2007022947A3 (fr) Composes 5-cycle-heteroaromates et leur utilisation en tant que partenaires de liaison des recepteurs 5-ht5
WO2008136394A1 (fr) Procédé de production d'un composé de lactame et intermédiaire pour le procédé de production
WO2006107062A3 (fr) Derive de benzimidazole et utilisation de celui-ci
WO2006134499A3 (fr) Derives de 2-(1h-indolylsulfanyl)-aryl amine
WO2008021346A3 (fr) Palipéridone pure et ses procédés d'obtention
WO2007131907A3 (fr) Dérivés de 1h-indol-5-yl-pipérazin-1-yl-méthanone
EP1896433A4 (fr) Nouvelles formes cristallines de (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)bi-phenyl-4-ylmethyl]-amine
WO2007069271A3 (fr) Procede de purification d'une (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine
WO2007002722A3 (fr) Procédé de purification d'un intermédiaire de l'anastrozole
WO2007009589A3 (fr) Utilisation d'activateurs de la guanylate cyclase soluble pour traiter les phenomenes de raynaud
WO2006128802A3 (fr) 3-methanesulfonylquinolines renforçant le gaba-b
WO2006063578A3 (fr) Procede de production de candesartan
WO2008019030A8 (fr) Composés d'azole modifiés en tant qu'agents anti-infectieux
WO2009009122A3 (fr) Dérivés de l'urée et de diamines associées, leurs procédés de fabrication, et leurs utilisations
WO2008035360A3 (fr) Nouvelles formes cristallines

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06848602

Country of ref document: EP

Kind code of ref document: A2